Comprehensive relief for the 21st century

Precision Medicine and Apheresis – A New Path in Modern Therapy

The medicine of the future is personalized, precise, and holistic. One of the most promising approaches of this new era is apheresis therapy, which selectively removes unwanted substances from the blood to treat inflammation, lipid disorders, and even chronic infection-related conditions.

In the following sections, we take a closer look at current scientific findings that highlight the potential of apheresis in various medical fields.

1. Lipoprotein Apheresis – More Than Just Lipid Reduction

Lipoprotein apheresis (LA) has established itself as a highly effective therapy for treating familial hypercholesterolemia and lipoprotein(a)-hyperlipidemia.

Despite being an invasive procedure, it demonstrates:

• High effectiveness in lipid reduction
• Minimal side effects
• Proven decrease in cardiovascular events

“Can apheresis do more than just lower cholesterol?”

Indeed, studies suggest that the benefits of LA extend beyond mere lipid reduction. It also removes pro-inflammatory and pro-atherogenic factors, leading to a more comprehensive reduction of cardiovascular risk.

Thus, lipoprotein apheresis stands at the center of a modern treatment strategy that combines effectiveness and safety.

2. Microplastics – The Invisible Threat to Health and Environment

Plastic pollution is no longer just an environmental issue. Microplastics have become a serious threat to food systems and human health.

“How strongly do microplastics affect our blood, our cells – and ultimately our well-being?”

Studies show that:

• Microplastics form when plastics break down into tiny particles
• These particles enter drinking water and food
  
• They can release toxic chemicals that:
  
  • Promote inflammation
  • Cause genotoxicity and carcinogenic effects
  • Trigger neurological and cardiovascular damage

The findings regarding nanoplastics (NPs) are particularly alarming – they indicate chronic toxicity that affects the liver, heart, and nervous system.

3. Lipid Profiles in Lyme Disease – A Possible Role for Apheresis

Lyme disease, caused by Borrelia burgdorferi, is a complex bacterial infection that can produce a wide range of symptoms. Recent research indicates a close connection between lipid metabolism and disease progression.

Scientific findings show that:

• Borrelia use host lipids for their survival
• Patients with Lyme disease display altered lipid profiles
  
• Elevated lipid levels can intensify disease severity
  

These insights lead to an exciting hypothesis:
Apheresis could help modulate inflammation and bacterial persistence through lipid reduction.

Early pilot studies support this innovative concept – further research is currently underway.

4. Post-COVID-19 and Chronic Fatigue Syndrome – Hope Through Extracorporeal Apheresis

Many patients continue to struggle with persistent symptoms following a SARS-CoV-2 infection, known as Post-COVID or Long-COVID. These include:

• Chronic fatigue
• Shortness of breath
• Cognitive impairment

This symptom pattern is strikingly similar to Chronic Fatigue Syndrome (CFS).

“What if the key to recovery lies within the blood itself?”

Current studies have detected elevated autoantibodies against neurotransmitter receptors in Long-COVID and CFS patients.

Extracorporeal apheresis offers a new therapeutic approach by:

• Reducing autoantibody concentrations in the blood
• Alleviating symptoms such as fatigue and cognitive difficulties
• Opening the door to novel treatment strategies

5. Particles in the Eluate of Double Filtration Plasmapheresis – Science in Detail

Source: Felix Scholkmann, Antonietta M. Gatti

Double Filtration Plasmapheresis (DFPP) is an advanced blood purification method closely associated with INUSpherese® technology.

A recent study examined which micro- and nanoparticles remain in the eluate after treatment.

“What remains once the blood has been cleansed?”

Using field emission scanning electron microscopy (FE-SEM-EDX), researchers identified particles containing:

• High concentrations of calcium, iron, silicon, aluminum, and titanium
  
• Traces that may reflect exogenous or endogenous exposure
  
• Markers relevant for environmental medical diagnostics
  

These findings emphasize that DFPP technology can be valuable not only therapeutically but also diagnostically.

6. INUSpherese® in Chronic Inflammation – An Innovative Approach

Chronic inflammation is considered the silent driver of many diseases – from autoimmune disorders to neurodegenerative conditions.

“Can we stop inflammation before it becomes disease?”

INUSpherese® therapy addresses this question by:

• Reducing inflammatory mediators, toxins, and oxidative stress
• Regulating immune system activity
• Stabilizing cellular metabolism

Typical indications for INUSpherese® include:

• Alzheimer’s disease
• Lyme disease
• Chronic Fatigue Syndrome (CFS)
• Hashimoto’s thyroiditis
• Leaky gut syndrome
• Mitochondrial disorders
• Nitrostress and oxidative stress

Conclusion – The Future of Precision Medicine

The studies presented here clearly demonstrate that apheresis is far more than a classic detoxification method.

It represents a precise, scientifically grounded approach that harmonizes metabolism, immune function, and cellular health.

With technologies like INUSpherese®, medicine is becoming increasingly individualized, aiming to treat diseases holistically – before they become chronic.

“Precision medicine begins where therapy is tailored to the biochemistry of the individual.”